These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2662369)

  • 1. [Non-steroidal anti-inflammatory agents. Prospects].
    Avouac B
    Rev Rhum Mal Osteoartic; 1989 Apr; 56(5 Pt 2):17-21. PubMed ID: 2662369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Chan FK; Graham DY
    Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-steroidal anti-inflammatory drugs in domestic animals: I. Their classification, mechanism of action and pharmacological effects.
    Swan GE
    J S Afr Vet Assoc; 1991 Mar; 62(1):35-8. PubMed ID: 2051448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forthcoming non-steroidal anti-inflammatory drugs: are they really devoid of side effects?
    Bjarnason I
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S27-36. PubMed ID: 10379467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon.
    Fiorucci S; Santucci L; Distrutti E
    Dig Liver Dis; 2007 Dec; 39(12):1043-51. PubMed ID: 17997373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newer cyclo-oxygenase-2 selective inhibitors, other non-steroidal anti-inflammatory drugs and the risk of acute pancreatitis.
    Sørensen HT; Jacobsen J; Nørgaard M; Pedersen L; Johnsen SP; Baron JA
    Aliment Pharmacol Ther; 2006 Jul; 24(1):111-6. PubMed ID: 16803609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospitalization for gastrointestinal adverse events attributable to the use of low-dose aspirin among patients 50 years or older also using non-steroidal anti-inflammatory drugs: a retrospective cohort study.
    Rahme E; Nedjar H; Bizzi A; Morin S
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1387-98. PubMed ID: 17892525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription-Event Monitoring. Recent experience with 5 NSAIDs.
    Rawson NS; Inman WH
    Med Toxicol; 1986; 1 Suppl 1():79-82. PubMed ID: 3821431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upper gastrointestinal tolerability of once weekly alendronate 70 mg with concomitant non-steroidal anti-inflammatory drug use.
    Cryer B; Miller P; Petruschke RA; Chen E; Geba GP; Papp AE
    Aliment Pharmacol Ther; 2005 Mar; 21(5):599-607. PubMed ID: 15740544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-steroidal anti-inflammatory agents (NSAID's) with lesser side effects by selective inhibition of cyclo-oxygenase-2].
    Bijlsma JW; Van de Putte LB
    Ned Tijdschr Geneeskd; 1998 Aug; 142(31):1762-5. PubMed ID: 9856140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prescription of non-steroidal anti-inflammatory agents and risk of iatrogenic adverse effects: a survey of 1072 French general practitioners].
    Coste J; Hanotin C; Leutenegger E
    Therapie; 1995; 50(3):265-70. PubMed ID: 7667811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological approach to the prevention of non-steroidal anti-inflammatory drug-induced gastropathy.
    Whittle BJ
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S43-7. PubMed ID: 10379469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-steroidal anti-inflammatory agents: a critical view].
    Guzmán L; Cerda C
    Rev Med Chil; 1989 Nov; 117(11):1279-85. PubMed ID: 2519806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preferential COX-2 inhibition: its clinical relevance for gastrointestinal non-steroidal anti-inflammatory rheumatic drug toxicity].
    Dammann HG
    Z Gastroenterol; 1999 Jan; 37(1):45-58. PubMed ID: 10091284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of peptic ulcer bleeding among users of traditional non-steroidal anti-inflammatory drugs and selective cyclo-oxygenase-2 inhibitors.
    Thomsen RW; Riis A; Christensen S; McLaughlin JK; Sørensen HT
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1431-8. PubMed ID: 17032286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
    Scarpignato C; Pelosini I
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S63-72. PubMed ID: 10379472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The non-steroidal anti-inflammatory drugs].
    Biscarini L; Del Favero A
    Medicina (Firenze); 1989; 9(3):249-64. PubMed ID: 2693879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prescription of non-steroidal anti-inflammatory drugs].
    Bannwarth B
    Bull Acad Natl Med; 1998; 182(7):1431-7; discussion 1437-8. PubMed ID: 9916337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.